Cargando…

Damage-associated molecular patterns in inflammatory bowel disease: From biomarkers to therapeutic targets

The chronic inflammatory process underlying inflammatory bowel disease (IBD), comprising Crohn’s disease and ulcerative colitis, derives from the interplay of several components in a genetically susceptible host. These components include environmental elements and gut microbiota a dysbiosis. For dec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nanini, Hayandra Ferreira, Bernardazzi, Claudio, Castro, Fernando, de Souza, Heitor Siffert Pereira
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6224468/ https://www.ncbi.nlm.nih.gov/pubmed/30416310 http://dx.doi.org/10.3748/wjg.v24.i41.4622

Ejemplares similares

Neuroimmunomodulation in the Gut: Focus on Inflammatory Bowel Disease
por: Bernardazzi, Claudio, et al.
Publicado: (2016)

Diet and microbiota in inflammatory bowel disease: The gut in disharmony
por: Rapozo, Davy C M, et al.
Publicado: (2017)

The Role of Innate Immunity Receptors in the Pathogenesis of Inflammatory Bowel Disease
por: Elia, Paula Peruzzi, et al.
Publicado: (2015)

Serum 1,3-beta-D-glucan as a noninvasive test to predict histologic activity in patients with inflammatory bowel disease
por: Farias e Silva, Katia, et al.
Publicado: (2021)

Interleukin-33 and Inflammatory Bowel Diseases: Lessons from Human Studies
por: Nunes, Tiago, et al.
Publicado: (2014)

Cell Death and Inflammatory Bowel Diseases: Apoptosis, Necrosis, and Autophagy in the Intestinal Epithelium
por: Nunes, Tiago, et al.
Publicado: (2014)

Schistosoma mansoni Coinfection Attenuates Murine Toxoplasma gondii-Induced Crohn's-Like Ileitis by Preserving the Epithelial Barrier and Downregulating the Inflammatory Response
por: Pêgo, Beatriz, et al.
Publicado: (2019)

Dietary Composition and Effects in Inflammatory Bowel Disease
por: Castro, Fernando, et al.
Publicado: (2019)

Hospitalization and surgery rates in patients with inflammatory bowel disease in Brazil: a time-trend analysis
por: Palacio, Flávia Gonçalves Musauer, et al.
Publicado: (2021)

Dysbiosis in Inflammatory Bowel Disease: Pathogenic Role and Potential Therapeutic Targets
por: Santana, Patricia Teixeira, et al.
Publicado: (2022)

P2X7 Receptor Modulation of the Gut Microbiota and the Inflammasome Determines the Severity of Toxoplasma gondii-Induced Ileitis
por: Moreira-Souza, Aline Cristina Abreu, et al.
Publicado: (2023)

Macrophage P2X7 Receptor Function Is Reduced during Schistosomiasis: Putative Role of TGF-β1
por: Oliveira, Suellen D'arc Santos, et al.
Publicado: (2014)

The P2X7 Receptor Promotes Colorectal Inflammation and Tumorigenesis by Modulating Gut Microbiota and the Inflammasome
por: Bernardazzi, Claudio, et al.
Publicado: (2022)

The Current Status of Molecular Biomarkers for Inflammatory Bowel Disease
por: Alghoul, Zahra, et al.
Publicado: (2022)

Inflammatory Bowel Disease Treatments and Predictive Biomarkers of Therapeutic Response
por: Elhag, Duaa Ahmed, et al.
Publicado: (2022)

Immunology of Inflammatory Bowel Disease: Molecular Mechanisms and Therapeutics
por: Lu, Quan, et al.
Publicado: (2022)

The Rise of Gastrointestinal Cancers as a Global Phenomenon: Unhealthy Behavior or Progress?
por: Jardim, Silvia Rodrigues, et al.
Publicado: (2023)

Damage-Associated Molecular Patterns in Inflammatory Diseases
por: Roh, Jong Seong, et al.
Publicado: (2018)

Serum Anti-Spike Antibodies Are Not Affected by Immunosuppressants in SARS-CoV-2 Vaccinations Given to Brazilian Patients with Inflammatory Bowel Disease
por: Pereira, Magno Luís Costa, et al.
Publicado: (2023)

Raman spectroscopic molecular fingerprinting of biomarkers for inflammatory bowel disease
por: Buchan, Emma, et al.
Publicado: (2023)

Biomarkers of Therapeutic Response in the IL-23 Pathway in Inflammatory Bowel Disease
por: Cayatte, Corinne, et al.
Publicado: (2012)

Bioactive Compounds from Pale Ale Beer Powder Attenuate Experimental Colitis in BALB/c Mice
por: Maia, Paola D. D. S., et al.
Publicado: (2022)

Biomarkers of Inflammatory Bowel Disease
por: Fengming, Yi, et al.
Publicado: (2014)

Biomarkers in management of inflammatory bowel disease
por: Moniuszko, Andrzej, et al.
Publicado: (2013)

Serum Biomarkers for Inflammatory Bowel Disease
por: Chen, Peng, et al.
Publicado: (2020)

Insights into the molecular mechanisms and therapeutic implications of interleukin-6 for inflammatory bowel disease
por: Tie, Yizhe, et al.
Publicado: (2023)

Serum miRNAs Are Pharmacodynamic Biomarkers Associated With Therapeutic Response in Pediatric Inflammatory Bowel Disease
por: Batra, Suruchi K, et al.
Publicado: (2020)

Evaluation of anti-TNF therapeutic response in patients with inflammatory bowel disease: Current and novel biomarkers
por: Cui, Guanglin, et al.
Publicado: (2021)

Novel Biomarkers and the Future Potential of Biomarkers in Inflammatory Bowel Disease
por: Duvoisin, Gilles, et al.
Publicado: (2017)

Cellular and Molecular Therapeutic Targets in Inflammatory Bowel Disease—Focusing on Intestinal Barrier Function
por: Schoultz, Ida, et al.
Publicado: (2019)

Identification of Novel Therapeutic Molecular Targets in Inflammatory Bowel Disease by Using Genetic Databases
por: Mohan, Sachin, et al.
Publicado: (2020)

Positioning and Usefulness of Biomarkers in Inflammatory Bowel Disease
por: Sakurai, Toshiyuki, et al.
Publicado: (2023)

Hedgehog Pathway Signaling Regulates Human Colon Carcinoma HT-29 Epithelial Cell Line Apoptosis and Cytokine Secretion
por: Yoshimoto, Agnes N., et al.
Publicado: (2012)

Therapeutic drug monitoring in inflammatory bowel disease
por: Kopylov, Uri, et al.
Publicado: (2014)

Catechins and Their Therapeutic Benefits to Inflammatory Bowel Disease
por: Fan, Fei-Yan, et al.
Publicado: (2017)

Therapeutic Oligonucleotides for Patients with Inflammatory Bowel Diseases
por: Marafini, Irene, et al.
Publicado: (2020)

Emerging therapeutic options in inflammatory bowel disease
por: Yamamoto-Furusho, Jesus K, et al.
Publicado: (2021)

Crohn's disease activity assessed by doppler sonography: the role of aortic flow parameters
por: Andrade, Thais Guaraná, et al.
Publicado: (2013)

Mitochondrial Damage-Associated Molecular Patterns: From Inflammatory Signaling to Human Diseases
por: Grazioli, Serge, et al.
Publicado: (2018)

Fecal Dipeptidyl Peptidase-4: An Emergent Biomarker in Inflammatory Bowel Disease
por: Pinto-Lopes, Pedro, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gfa2f0t8o9sfqqf4dcp540o5ji